Brett Sandercock - 08 Jul 2024 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
08 Jul 2024
Transactions value $
-$194,350
Form type
4
Filing time
09 Jul 2024, 17:27:06 UTC
Previous filing
11 Jun 2024
Next filing
12 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$194K -1K -1.1% $194.35 90.1K 08 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.